Activation of Vα14+ natural killer T cells by α-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans

Infection and Immunity

Volumn 69, Issue 1, 2001, Pages 213-220

  Kawakami, K ^a   Kinjo, Y ^a   Yara, S ^a   Koguchi, Y ^a   Uezu, K ^a   Nakayama, T ^a   Taniguchi, M ^a   Saito, A ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GALACTOSYLCERAMIDE; GAMMA INTERFERON; MONOCLONAL ANTIBODY; CD4 ANTIGEN; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG MECHANISM; HOST RESISTANCE; IMMUNE RESPONSE; LUNG ALVEOLUS CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CRYPTOCOCCOSIS; IMMUNOLOGY; LUNG; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; MOUSE MUTANT; PHYSIOLOGY; SPLEEN;

ANIMALS; ANTIGENS, CD4; CRYPTOCOCCOSIS; GALACTOSYLCERAMIDES; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SPLEEN; TH1 CELLS;

EID: 0034746796     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.1.213-220.2001     Document Type: Article

References (42)

1. Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls
2. An NK1.1+CD4+CD8- single-positive thymocyte subpopulation that express a highly skewed T-cell antigen receptor Vβ family
3. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates
4. β2-Microglobulin-dependent NK1.1+T cells are not essential for T helper cell 2 immune responses
5. Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells
6. Specific immunity and cytokines
7. Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice
8. Early quantitative and functional deficiency of NK1+ like thymocytes in the NOD mouse
9. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors
10. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer cells
11. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans
12. A role for CD4+NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection
13. A novel population of T-cell receptor αβ-bearing thymocytes which predominantly expresses a single Vβ gene family
14. α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria
15. Selective development of T helper (Th) 2 cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulin-deficient BALB/c mice
16. α/β-T cell receptor (TCR)+CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)4 and/or IL-10
17. Lipid antigen presentation in the immune system: Lessons learned from CD1d knockout mice
18. The role of intrahepatic Vα14+ NK1.1+ T cells for liver injury induced by Salmonella infection in mice
19. Interleukin-4 and listeriosis
20. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: Effects of interleukin-12
21. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with intefferon-γ-inducing cytokines
22. Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice
23. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides
24. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells
25. The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells
26. KRN7000, a novel immunomodulator, and its antitumor activities
27. An invariant T cell receptor a chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-CD8- T cells in mice and humans
28. Predominant expression of invariant Vα14+ TCRα chain in NK1.1 + T cell populations
29. Phenotypes and invariant αβ TCR expression of peripheral Vα14+ NK T cells
30. Selective reduction of Vα14+ NK T cells associated with disease development in autoimmune-prone mice
31. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells
32. Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
33. Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells
34. Fungal infections in AIDS patients
35. Liver NK1.1+CD4+ αβ T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis
36. Inhibition of experimental tumor metastasis by dendritic cells pulsed with α-galactosylceramide
37. Participation of NK1.1+ T cells in the rejection of lpr αβT cells when bone marrow cells of lpr mice are transplanted into B6 mice
38. Extreme Th1 bias of invariant Vα24JαQ T cells in type-1 diabetes
39. Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis
40. Role of NK1.1 +T cells in a TH2-response and in immunoglobulin E production
41. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice
42. β2-Microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses